Healthcare
Thursday, July 21, 2016
Teva opens books on SFr1bn three-tranche bond
LONDON, July 21 (IFR) - Teva Pharmaceutical has started
marketing a SFr1bn three-tranche bond issue to help fund its
US$40.5bn acquisition of Actavis Generics, according to a lead
bank.
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment